Envestnet Asset Management Inc. boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 184,180 shares of the company's stock after purchasing an additional 23,849 shares during the period. Envestnet Asset Management Inc. owned about 0.11% of Option Care Health worth $6,437,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Public Employees Retirement System of Ohio grew its stake in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares during the last quarter. State of Alaska Department of Revenue raised its position in Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after buying an additional 525 shares during the last quarter. Mackenzie Financial Corp raised its position in Option Care Health by 1.1% in the 4th quarter. Mackenzie Financial Corp now owns 49,579 shares of the company's stock worth $1,150,000 after buying an additional 556 shares during the last quarter. Bessemer Group Inc. raised its position in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the last quarter. Finally, Sheets Smith Wealth Management raised its position in Option Care Health by 2.6% in the 1st quarter. Sheets Smith Wealth Management now owns 24,481 shares of the company's stock worth $856,000 after buying an additional 625 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Stock Performance
OPCH stock traded up $0.22 during trading on Friday, reaching $29.69. The stock had a trading volume of 1,176,629 shares, compared to its average volume of 1,842,128. The stock's 50 day moving average is $31.39 and its two-hundred day moving average is $31.78. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The firm has a market cap of $4.86 billion, a PE ratio of 23.94, a PEG ratio of 1.96 and a beta of 0.73.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter last year, the company earned $0.26 earnings per share. The business's revenue for the quarter was up 16.3% compared to the same quarter last year. As a group, equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
Wall Street Analysts Forecast Growth
OPCH has been the subject of a number of recent analyst reports. JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Wednesday, June 18th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.
Get Our Latest Stock Report on Option Care Health
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
